@prefix dcterms: <http://purl.org/dc/terms/> .
@prefix dcat: <http://www.w3.org/ns/dcat#> .
@prefix foaf: <http://xmlns.com/foaf/0.1/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ldp: <http://www.w3.org/ns/ldp#> .

<http://data.europa.eu/nuts/code/BE> a dcterms:Location .

<http://healthdataportal.eu/resource/authority/healthcategories/EHCT> a <http://www.w3.org/2004/02/skos/core#Concept>;
  <http://www.w3.org/2004/02/skos/core#prefLabel> """
                                        Data from clinical trials, clinical studies and clinical investigations subject
                                        to Regulation (EU) 536/2014, Regulation [SOHO], Regulation (EU) 2017/745 and
                                        Regulation (EU) 2017/746, respectively"""@en .

<http://publications.europa.eu/resource/authority/access-right/NON_PUBLIC> a dcterms:RightsStatement .

<http://publications.europa.eu/resource/authority/data-theme/HEAL> a <http://www.w3.org/2004/02/skos/core#Concept>;
  <http://www.w3.org/2004/02/skos/core#prefLabel> """
                                        Health"""@en .

<http://publications.europa.eu/resource/authority/dataset-type/PERSONAL_DATA> a <http://www.w3.org/2004/02/skos/core#Concept>;
  <http://www.w3.org/2004/02/skos/core#prefLabel> """
                                        Personal Data"""@en .

<https://eur-lex.europa.eu/eli/reg/2025/327/oj> a <http://data.europa.eu/eli/ontology#LegalResource> .

<http://publications.europa.eu/resource/authority/frequency/NEVER> a dcterms:Frequency .

<datasetContactPoint:1772620597739-8bf93d5c-0> a <http://www.w3.org/2006/vcard/ns#Kind>,
    <http://www.w3.org/2006/vcard/ns#Organization>;
  <http://www.w3.org/2006/vcard/ns#fn> "Stéphanie Depickère";
  <http://www.w3.org/2006/vcard/ns#hasEmail> <mailto:stephanie.depickere@sciensano.be>;
  <http://www.w3.org/2006/vcard/ns#hasURL> <https://www.sciensano.be/en/projects/belgian-sars-cov-2-vaccination-studies>;
  <http://www.w3.org/2006/vcard/ns#organisationName> "Sciensano";
  <http://www.w3.org/2006/vcard/ns#organisationUnit> "1203" .

<datasetHasLegalBasis:1772620597740-169515dc-0> a <https://w3id.org/dpv#LegalBasis>;
  dcterms:source <https://eur-lex.europa.eu/eli/reg/2014/536/2022-12-05>;
  dcterms:description "Clinical Trial Regulation"@en .

<datasetProvenance:1772620597739-672ed6ab-0> a dcterms:ProvenanceStatement;
  <http://www.w3.org/2000/01/rdf-schema#label> "Pseudonymised dataset, ethical approval granted"@en .

<https://intranet-fdp.sciensano.be/dataset/dcf9d125-6513-49d5-9ada-3dd6a1fafb72#admsIdentifier>
  a <http://www.w3.org/ns/adms#Identifier>;
  <http://www.w3.org/2004/02/skos/core#notation> "https://intranet-fdp.sciensano.be/dataset/dcf9d125-6513-49d5-9ada-3dd6a1fafb72"^^xsd:anyURI .

<https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f> a dcat:Resource,
    dcat:Dataset;
  dcterms:accessRights <http://publications.europa.eu/resource/authority/access-right/NON_PUBLIC>;
  dcterms:identifier "https://intranet-fdp.sciensano.be/dataset/dcf9d125-6513-49d5-9ada-3dd6a1fafb72"^^xsd:anyURI;
  dcterms:language <http://id.loc.gov/vocabulary/iso639-1/en>;
  dcterms:license <http://purl.org/NET/rdflicense/cc-zero1.0>;
  <https://w3id.org/fdp/fdp-o#metadataIdentifier> <https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f#identifier>;
  <https://w3id.org/fdp/fdp-o#metadataIssued> "2026-07-22T23:02:00.298Z"^^xsd:dateTime;
  <https://w3id.org/fdp/fdp-o#metadataModified> "2026-07-22T23:02:32.479Z"^^xsd:dateTime;
  <http://semanticscience.org/resource/SIO_000628> <https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f/metrics/445c0a70d1e214e545b261559e2842f4>,
    <https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f/metrics/5d27e854a9e78eb3f663331cd47cdc13>;
  dcterms:isPartOf <https://public-fdp.sciensano.be/catalog/84539216-5daf-4d76-b112-f8723fe0f8c6>;
  <http://technical.fdp/modified> "2026-07-22T23:01:14.000Z"^^xsd:dateTime;
  <http://technical.fdp/sciensanoTheme> <http://www.wikidata.org/entity/Q5382704>;
  <http://data.europa.eu/r5r/applicableLegislation> <https://eur-lex.europa.eu/eli/reg/2025/327/oj>;
  <http://healthdataportal.eu/ns/health#hdab> <hdab:1>;
  <http://healthdataportal.eu/ns/health#healthCategory> <http://healthdataportal.eu/resource/authority/healthcategories/EHCT>;
  dcterms:provenance <datasetProvenance:1772620597739-672ed6ab-0>;
  dcterms:spatial <http://data.europa.eu/nuts/code/BE>;
  dcterms:type <http://publications.europa.eu/resource/authority/dataset-type/PERSONAL_DATA>;
  <http://technical.fdp/sciensanoOrg> "1203";
  <http://www.w3.org/ns/adms#identifier> <https://intranet-fdp.sciensano.be/dataset/dcf9d125-6513-49d5-9ada-3dd6a1fafb72#admsIdentifier>;
  dcat:contactPoint <datasetContactPoint:1772620597739-8bf93d5c-0>;
  dcat:keyword "COVID-19"@en, "Adverse events"@en, "Immunology"@en, "Vaccination"@en,
    "Healthy population"@en, "Reduced-dose"@en;
  dcat:theme <http://publications.europa.eu/resource/authority/data-theme/HEAL>;
  <https://w3id.org/dpv#hasLegalBasis> <datasetHasLegalBasis:1772620597740-169515dc-0>;
  <http://healthdataportal.eu/ns/health#numberOfRecords> "128"^^xsd:nonNegativeInteger;
  <http://healthdataportal.eu/ns/health#populationCoverage> "Healthy people"@en;
  dcterms:accrualPeriodicity <http://publications.europa.eu/resource/authority/frequency/NEVER>;
  dcterms:temporal [ a dcterms:PeriodOfTime;
      dcat:endDate "2022-01-01"^^xsd:date;
      dcat:startDate "2021-01-01"^^xsd:date
    ];
  dcat:distribution <https://public-fdp.sciensano.be/distribution/3c1d0654-a7a5-4b5d-8dae-047dca121478>;
  <http://www.w3.org/2000/01/rdf-schema#label> "Safety and immunogenicity of demi-dose of two Covid-19 mRNA vaccines in healthy population (Redu-VAC)- Dose 3";
  foaf:page <https://www.sciensano.be/en/projects/belgian-sars-cov-2-vaccination-studies>;
  dcterms:description "Une collecte de données (analyses en laboratoire et enquêtes) auprès d'une cohorte belge de personnes en bonne santé travaillant sur cinq sites à travers la Belgique pour le « Département externe de prévention et de protection au travail » de Mensura et pour la société Carglass. Les données concernent l'immunité des participants avant et après la vaccination contre la COVID-19 (dose 3) à l'aide du vaccin à ARNm contre la COVID-19 BTB162b2. Redu-VAC est une étude randomisée, multicentrique et de non-infériorité qui examine la sécurité, la réactogénicité et l'immunogénicité d'une dose de rappel fractionnée (10 µg contre 30 µg) du vaccin. Les événements indésirables liés à la vaccination sont disponibles. L'enquête auprès des participants sur leur état de santé est également disponible."@fr,
    "A collection of data (lab analysis and surveys) from a Belgian cohort of healthy people working at five sites across Belgium of the ‘External Department of Prevention and Protection at work’ of Mensura and at Carglass company. Data are about participants' immunity previous and after COVID-19 vaccination (dose 3) using mRNA COVID-19 vaccine BTB162b2. Redu-VAC is a randomised, multicenter, non-inferiority study investigating safety, reactogenicity and immunogenicity of a fractional booster dose (10µg versus 30µg) of the vaccine. Adverse events linked to the vaccination are available. Participants' survey with their health status is also available."@en,
    "Een verzameling van gegevens (laboratoriumanalyses en enquêtes) van een Belgische cohort van gezonde mensen die werkzaam zijn op vijf locaties in België van de ‘Externe Dienst voor Preventie en Bescherming op het Werk’ van Mensura en bij het bedrijf Carglass. De gegevens hebben betrekking op de immuniteit van de deelnemers vóór en na COVID-19-vaccinatie (dosis 3) met het mRNA COVID-19-vaccin BTB162b2. Redu-VAC is een gerandomiseerde, multicentrische, non-inferioriteitsstudie waarin de veiligheid, reactogeniciteit en immunogeniciteit van een fractionele boosterdosis (10 µg versus 30 µg) van het vaccin worden onderzocht. Er zijn gegevens beschikbaar over bijwerkingen die verband houden met de vaccinatie. Er is ook een enquête beschikbaar over de gezondheidstoestand van de deelnemers."@nl;
  dcterms:publisher [ a foaf:Agent;
      dcterms:type <http://healthdataportal.eu/resource/authority/publisher-type/nationalPublicHealthInstitute>;
      foaf:name "Sciensano";
      dcterms:description "Sciensano is a research institute and the national public health institute of Belgium. It is a so-called federal scientific institution that operates under the authority of the federal minister of Public Health and the federal minister of Agriculture of Belgium."@en
    ];
  dcterms:title "Safety and immunogenicity of demi-dose of two Covid-19 mRNA vaccines in healthy population (Redu-VAC)- Dose 3"@en,
    "Sécurité et immunogénicité d'une demi-dose de deux vaccins à ARNm contre la Covid-19 chez une population en bonne santé (Redu-VAC) - Dose 3"@fr,
    "Veiligheid en immunogeniciteit van een halve dosis van twee Covid-19-mRNA-vaccins bij een gezonde populatie (Redu-VAC) - Dosis 3"@nl;
  dcterms:conformsTo <https://public-fdp.sciensano.be/profile/2f08228e-1789-40f8-84cd-28e3288c3604> .

<https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f/metrics/445c0a70d1e214e545b261559e2842f4>
  <http://semanticscience.org/resource/SIO_000332> <https://www.ietf.org/rfc/rfc3986.txt>;
  <http://semanticscience.org/resource/SIO_000628> <https://www.ietf.org/rfc/rfc3986.txt> .

<https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f/metrics/5d27e854a9e78eb3f663331cd47cdc13>
  <http://semanticscience.org/resource/SIO_000332> <https://www.wikidata.org/wiki/Q8777>;
  <http://semanticscience.org/resource/SIO_000628> <https://www.wikidata.org/wiki/Q8777> .

<https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f#identifier>
  a <http://purl.org/spar/datacite/Identifier>;
  dcterms:identifier "https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f" .

<https://public-fdp.sciensano.be/distribution/> a ldp:DirectContainer;
  dcterms:title "Distributions";
  ldp:membershipResource <https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f>;
  ldp:hasMemberRelation dcat:distribution;
  ldp:contains <https://public-fdp.sciensano.be/distribution/3c1d0654-a7a5-4b5d-8dae-047dca121478> .

<https://public-fdp.sciensano.be/sample/> a ldp:DirectContainer;
  dcterms:title "Samples";
  ldp:membershipResource <https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f>;
  ldp:hasMemberRelation <http://www.w3.org/ns/adms#sample> .

<https://public-fdp.sciensano.be/analytics/> a ldp:DirectContainer;
  dcterms:title "Analytics";
  ldp:membershipResource <https://public-fdp.sciensano.be/dataset/6580937e-916f-4653-a303-8c16f788e92f>;
  ldp:hasMemberRelation <http://healthdataportal.eu/ns/health#analytics> .

<https://public-fdp.sciensano.be/profile/2f08228e-1789-40f8-84cd-28e3288c3604> <http://www.w3.org/2000/01/rdf-schema#label>
    "Dataset Profile" .